Gri BioGRI
13F holders, Q1 2026 (March 31)6holders +5
5new positions
0sold out
$2.29avg. 13F price*
At the end of Q1 2026, 6 institutions reported holding Gri Bio Inc. (GRI) in their 13F filings, up 5 from Q4 2025. 5 opened new positions and 0 sold out. The largest holders were Geode Capital Management, LLC ($42K), UBS Group AG ($20K) and Tower Research Capital LLC (TRC) ($2K).
- Company
- Gri Bio Inc.
- CUSIP
- 3622AW502
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $65K |
| Exits | 0 | $0 |
All 13F filers, Q4 2025 → Q1 2026: 28,229 shares bought and 113 shares sold, net +28,116 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 6 holders
| Geode Capital Management, LLC | 0.00% | New | 18,438 | $42K |
| UBS Group AG | 0.00% | New | 8,722 | $20K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 1,060 | $2K |
| BlackRock, Inc. | 0.00% | New | 7 | $16 |
| SBI Securities Co., Ltd. | 0.00% | Reduce -96.6% | 4 | $9 |
| Danske Bank A/S | 0.00% | New | 2 | $5 |
"% of holder's portfolio" is GRI's weight in each manager's 13F, not the share of Gri Bio Inc. the manager owns.